Sinus tachycardia is defined as increase in the sinus rate above 160 to 180 bpm in infants. Some other findings that suggest a pathologic mechanism of tachycardia are: 1. The presence of minimal or absent heart rate variability 2. Abnormal P-wave morphology or axis (normally upright in leads I and aVF) on ECG 3. Prolongation of PR interval The best method for initial evaluation of sinus tachycardia typically involves obtaining an ECG to ensure that there is no evidence of a pathologic arrhythmia. Similar to sinus bradycardia, a 24-hour Holter can be helpful in making the diagnosis in questionable cases. In children with sinus arrhythmia, sometimes called respiratory sinus arrhythmia, phasic variations in heart rate are seen with an increase in heart rate during inspiration and a decrease in heart rate with expiration (Figure 86-1). This condition is physiologic and does not require any treatment or follow-up. The typical rate of neonatal atrial flutter is between 300 and 600 beats per minute. However, the ventricular rate is much less, due to the decremental properties of the AV node not allowing for such rapid conduction. The conduction to the ventricles is generally 2 : 1, 3 : 1, or 4 : 1 (Figure 86-2) and may vary among these conduction rates, resulting in an irregular rhythm. Occasionally, the AV conduction can be very rapid, resulting in ventricular rates greater than 200 bpm, which may be poorly tolerated by the fetus and neonate alike. The initial therapy to treat atrial flutter typically involves synchronized electrical cardioversion with 0.5 to 2 Joules per kilogram.4,10 The best position for the paddles is front to back on the left side of the chest, and it is often necessary to turn the infant on its side to get the paddles into position. Rapid atrial pacing (overdrive pacing) may also terminate the tachycardia, but may be difficult to achieve with the rapid atrial rate seen in neonatal flutter and has a lower overall success rate.12,19 In addition to these two methods, some physicians use antiarrhythmic medications and observe for up to 48 hours to see if the tachycardia terminates spontaneously. Atrial flutter in an otherwise healthy newborn tends not to return once the patient is successfully treated unless there is underlying congenital heart disease or another arrhythmia such as atrial tachycardia. Therefore, no routine antiarrhythmic treatment is necessary for either short- or long-term treatment of standard atrial flutter.4,10,12,19 If there is underlying atrial dilation, recurrent atrial flutter, or structural heart disease, treatment with antiarrhythmic medications such as digoxin may be warranted. Neonatal atrial fibrillation (AFib) is an exceptionally rare dysrhythmia in this patient population and is typically seen only in patients with structural congenital heart disease (such as Ebstein anomaly of the tricuspid valve) or in conjunction with an accessory pathway (Wolff-Parkinson-White).24 Supraventricular tachycardia (SVT) caused by a reentrant mechanism is the most common form of SVT in this population. In a reentrant tachycardia, there are two distinct conducting pathways linked around an area of nonconducting tissue. Failure to conduct in one of these pathways (block) causes the impulse to turn around in the other pathway, creating an electrical loop that causes tachycardia (Figure 86-3). There are two common reentrant mechanisms of supraventricular tachycardia seen in the pediatric population. The first, and by far the most common in newborns and infants, is caused by an accessory pathway.2 The second form is due to reentry around the atrioventricular node, also known as atrioventricular nodal reentry tachycardia or AVNRT. If an accessory pathway is present, it serves as an additional conduction pathway for electrical impulses to travel between the atria to the ventricles. Accessory pathways are able to conduct an impulse in both directions (antegrade from atria to ventricles and retrograde from ventricles to atria), or only in one direction—either exclusively from the atria to the ventricles or from the ventricles to the atria. If an accessory pathway is capable of conducting the impulse only from the ventricles to the atria (retrograde), it is referred to as a concealed accessory pathway, and the baseline ECG will appear normal. If an accessory pathway is capable of conducting an impulse from the atria to the ventricles, it is referred to as a manifest accessory pathway,13 resulting in what is known as preexcitation on the baseline ECG. Patients with preexcitation (also called Wolff-Parkinson-White [WPW]) have an area of early ventricular activation on their ECG. This early ventricular activation on the ECG is called a delta wave, and results in a short PR interval and widened QRS complex (Figure 86-4). Preexcitation is present because the electrical impulse travels from the atria to the ventricles over two pathways—through the AV node/bundle of His, which has decremental properties, and down the accessory pathway. When activation travels down the conduction system (AV node), a normal physiologic delay of conduction occurs. This delay is necessary to make sure that atrial systole will occur before ventricular systole. Although there is a delay in conduction through the AV node, no such delay exists when a manifest accessory pathway is present. Therefore, the atrial impulse travels quickly from the atria to the ventricles across the accessory pathway and activates the ventricular myocardium quickly. This manifests as a delta wave on the ECG. About 20% of patients with Wolff-Parkinson-White have underlying structural heart disease (most commonly Ebstein anomaly); therefore, an echocardiogram should be performed when the diagnosis is made. Wolff-Parkinson-White syndrome can be hereditary, but most times is sporadic, occurring in about 1 to 3 per 1000 individuals.21 Patients with WPW, a manifest accessory pathway, have an increased risk of atrial fibrillation for reasons that are not well understood. If atrial fibrillation occurs in a patient with WPW, an irregularly irregular wide complex tachycardia ensues (Figure 86-5). In infants and neonates, there are almost no other causes of an irregularly wide complex tachycardia other than atrial fibrillation in the presence of an accessory pathway, although this occurrence is extremely rare in infants and neonates. Patients with WPW and atrial fibrillation also have the risk of sudden cardiac death.16 In atrial fibrillation, these accessory pathways may rapidly conduct the atrial impulses to the ventricles, resulting in rapid ventricular activation that can degenerate into ventricular fibrillation and results in cardiac arrest. For this reason, adenosine, which blocks AV nodal conduction, should only be used in a very controlled environment. Patients with a concealed accessory pathway are at risk of developing supraventricular tachycardia secondary to a reentrant mechanism.9,31 Supraventricular tachycardia is usually initiated by a premature atrial or ventricular contraction. The premature beat will block in one of these two conduction pathways—the accessory pathway or the AV node. If the premature beat blocks in the accessory pathway, the activation wavefront travels down the normal conduction system (AV node and bundle of His) to the ventricles. The conduction wavefront then passes through the ventricular myocardium. The wavefront then reaches the accessory pathway, which has had time to recover and is able to conduct electrical impulses. The electrical impulse travels retrograde, from the ventricle to the atria, then back down the AV node to perpetuate the tachycardia. This type of tachycardia, known as orthodromic tachycardia, is generally a narrow complex in nature as it travels down the normal conduction system to get to the ventricles. Each of the components of this circuit is integral to allow for propagation of the tachycardia, and disruption of the circuit in any of the limbs will terminate the tachycardia (Figure 86-6). Another form of reentrant tachycardia seen in neonates is atrioventricular nodal reentry tachycardia (AVNRT). In this form of SVT, the entire circuit is contained within the proximal portion of the AV node and no true accessory pathway is present. Its reentry circuit is located between the slow and fast pathway limbs of the atrioventricular node.3,11 In most individuals, the AV node has both of these inputs, which coalesce to form the compact AV node, and which then continues to the bundle of His. Because slow and fast pathways have different conduction properties, a reentry tachycardia between these inputs can and often does occur. The resulting tachycardia is referred to as atrioventricular nodal reentry. Because AVNRT has a reentry mechanism, it is usually started by a premature atrial or ventricular beat. On ECG, it usually presents as a narrow complex tachycardia that is indistinguishable from an accessory pathway-mediated tachycardia. Atrioventricular nodal reentry tachycardia has a developmental component and is quite rare in neonates and infants, but is relatively common as a mechanism of tachycardia in older teenagers and adults.2
Disorders of Cardiac Rhythm and Conduction in Newborns
Normal Sinus Rhythm and Sinus Node Dysfunction
Normal Sinus Rhythm and Its Variations
Sinus Tachycardia
Sinus Arrhythmia
Tachyarrhythmias
Atrial Tachycardia
Premature Atrial Contractions
Atrial Flutter
Atrial Fibrillation
Reentrant Supraventricular Tachycardia
Supraventricular Tachycardia Caused by a Manifest Accessory Pathway
Supraventricular Tachycardia Caused by a Concealed Accessory Pathway
Supraventricular Tachycardia Caused By Atrioventricular Nodal Reentry Tachycardia
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree